Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
8
×
archive
clinical trials
life sciences
medical
national blog main
alnylam pharmaceuticals
boston
boston blog main
boston top stories
drugs
medicine
onpattro
patisiran
recalls
rna interference
safety
san francisco blog main
san francisco top stories
acute hepatic porphyrias
akcea therapeutics
akin akinc
aminolevulinic acid
andrew fire
blood pressure medication
cannabidiol
craig mello
dravet syndrome
epidiolex
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
hereditary transthyretin amyloidosis
inotersen
john maraganore
lennox-gastaut syndrome
losartan
national top stories
new york blog main
What
fda
8
×
pharmaceuticals
8
×
drug
recall
blood
cancer
pressure
expands
medicine
ago
alnylam
announced
approved
consumers
expanding
high
impurity
medication
recalled
risk
rnai
torrent
weeks
acella
advised
advisory
afternoon
alerted
alnylam’s
approval
april
battle
bee
cannabis
causing
company
concerns
data
derivative
determine
Language
unset
Current search:
pharmaceuticals
×
fda
×
fda
×
@slashgear.com
2 years ago
Blood pressure and fluid retention drugs recalled over cancer concerns
@slashgear.com
3 years ago
Popular thyroid drug recalled because it’s ‘super potent’ says FDA
@bgr.com
4 years ago
FDA expands recall of blood pressure meds due to cancer-causing impurity
@slashgear.com
4 years ago
High blood pressure drug recall expands again over cancer risk
@slashgear.com
4 years ago
Blood pressure medication recall expands over cancer risk
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug